J Korean Pediatr Soc.  2002 Aug;45(8):1033-1037.

A Case of Non-traumatic Rhabdomyolysis after Doxylamine Overdose

Affiliations
  • 1Department of Pediatrics, College of Medicine, Younsei University, Seoul, Korea. kkim@nhimc.or.kr
  • 2Department of Pediatrics, National Health Insurance Corporation, Ilsan Hospital, Koyang, Korea.

Abstract

Doxylamine is an antihistamine of the ethanolamine class. It is used primarily as a sleep-inducing agent. Clinicians should be aware of the complications in rhabdomyolysis patients who ingest doxylamine succinate and over-the-counter antihistamines. The easy availability of these substances increases the potential not only of intentional overdose by adults but also of inadvertent ingestion by children. Prompt intervention and careful assessment of renal function, urinary output, and serum creatine kinase levels may represent the difference between an uncomplicated and acute renal failure. Recognition of the potential for rhabdomyolysis and institution of vigorous treatment may prevent acute renal failure in patients who have taken an overdose of the drug. A 14-year-old male was found to have hematuria and oliguria. Evaluation of the patient revealed myoglobinuria, and a creatine kinase(CK) level of 117,563 IU/L. He was recovered by massive fluid administration, urine alkalization and mannitol infusion. We report a case of a suicide attempt in a child where ingestion of the doxylamine complicated by non-traumatic rhabdomyolysis with brief review related literatures.

Keyword

Doxylamine; Rhabdomyolysis

MeSH Terms

Acute Kidney Injury
Adolescent
Adult
Child
Creatine
Creatine Kinase
Doxylamine*
Eating
Ethanolamine
Hematuria
Histamine Antagonists
Humans
Male
Mannitol
Myoglobinuria
Oliguria
Rhabdomyolysis*
Succinic Acid
Suicide
Creatine
Creatine Kinase
Doxylamine
Ethanolamine
Histamine Antagonists
Mannitol
Succinic Acid
Full Text Links
  • KJP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr